These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 10873111)
61. Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment. Hopkins-Donaldson S; Cathomas R; Simões-Wüst AP; Kurtz S; Belyanskaya L; Stahel RA; Zangemeister-Wittke U Int J Cancer; 2003 Aug; 106(2):160-6. PubMed ID: 12800189 [TBL] [Abstract][Full Text] [Related]
62. Effects of BCL-2 suppression by antisense oligonucleotides on additional regulators of apoptosis compensatory change in non-targeted protein expression. Rubenstein M; Hollowell CM; Guinan P In Vivo; 2011; 25(5):725-32. PubMed ID: 21753125 [TBL] [Abstract][Full Text] [Related]
63. Analysis of ribosyl-modified, mixed backbone analogs of a bcl-2/bcl-xL antisense oligonucleotide. Olie RA; Hall J; Natt F; Stahel RA; Zangemeister-Wittke U Biochim Biophys Acta; 2002 Jun; 1576(1-2):101-9. PubMed ID: 12031489 [TBL] [Abstract][Full Text] [Related]
64. Trastuzumab down-regulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene--amplified breast cancer cells. Milella M; Trisciuoglio D; Bruno T; Ciuffreda L; Mottolese M; Cianciulli A; Cognetti F; Zangemeister-Wittke U; Del Bufalo D; Zupi G Clin Cancer Res; 2004 Nov; 10(22):7747-56. PubMed ID: 15570009 [TBL] [Abstract][Full Text] [Related]
65. p53-Independent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide. Strasberg Rieber M; Zangemeister-Wittke U; Rieber M Clin Cancer Res; 2001 May; 7(5):1446-51. PubMed ID: 11350916 [TBL] [Abstract][Full Text] [Related]
66. Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product. Smythe WR; Mohuiddin I; Ozveran M; Cao XX J Thorac Cardiovasc Surg; 2002 Jun; 123(6):1191-8. PubMed ID: 12063468 [TBL] [Abstract][Full Text] [Related]
68. Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide. Klasa RJ; Bally MB; Ng R; Goldie JH; Gascoyne RD; Wong FM Clin Cancer Res; 2000 Jun; 6(6):2492-500. PubMed ID: 10873104 [TBL] [Abstract][Full Text] [Related]
69. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity. Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666 [TBL] [Abstract][Full Text] [Related]
70. Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death. Jiang Z; Zheng X; Rich KM J Neurochem; 2003 Jan; 84(2):273-81. PubMed ID: 12558990 [TBL] [Abstract][Full Text] [Related]
71. Inhibition of BCL-2 in small cell lung cancer cell lines with oblimersen, an antisense BCL-2 oligodeoxynucleotide (ODN): in vitro and in vivo enhancement of radiation response. Loriot Y; Mordant P; Brown BD; Bourhis J; Soria JC; Deutsch E Anticancer Res; 2010 Oct; 30(10):3869-78. PubMed ID: 21036697 [TBL] [Abstract][Full Text] [Related]
72. Downregulation of Bcl-xL and activation of caspases during retinoic acid-induced apoptosis in an adult T-cell leukemia cell line. Fujimura S; Suzumiya J; Yamada Y; Kuroki M; Ono J Hematol J; 2003; 4(5):328-35. PubMed ID: 14502257 [TBL] [Abstract][Full Text] [Related]
74. Tumor regression by combination antisense therapy against Plk1 and Bcl-2. Elez R; Piiper A; Kronenberger B; Kock M; Brendel M; Hermann E; Pliquett U; Neumann E; Zeuzem S Oncogene; 2003 Jan; 22(1):69-80. PubMed ID: 12527909 [TBL] [Abstract][Full Text] [Related]
75. Identification of a human cDNA encoding a novel Bcl-x isoform. Ban J; Eckhart L; Weninger W; Mildner M; Tschachler E Biochem Biophys Res Commun; 1998 Jul; 248(1):147-52. PubMed ID: 9675101 [TBL] [Abstract][Full Text] [Related]
76. Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis. Komatsu K; Miyashita T; Hang H; Hopkins KM; Zheng W; Cuddeback S; Yamada M; Lieberman HB; Wang HG Nat Cell Biol; 2000 Jan; 2(1):1-6. PubMed ID: 10620799 [TBL] [Abstract][Full Text] [Related]
77. The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells. Doi S; Soda H; Oka M; Tsurutani J; Kitazaki T; Nakamura Y; Fukuda M; Yamada Y; Kamihira S; Kohno S Mol Cancer Ther; 2004 Nov; 3(11):1397-402. PubMed ID: 15542778 [TBL] [Abstract][Full Text] [Related]
78. Changes in gene expression induced by phosphorothioate oligodeoxynucleotides (including G3139) in PC3 prostate carcinoma cells are recapitulated at least in part by treatment with interferon-beta and -gamma. Benimetskaya L; Wittenberger T; Stein CA; Hofmann HP; Weller C; Lai JC; Miller P; Gekeler V Clin Cancer Res; 2004 Jun; 10(11):3678-88. PubMed ID: 15173074 [TBL] [Abstract][Full Text] [Related]
79. Down-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress HER2/neu. Roh H; Pippin J; Drebin JA Cancer Res; 2000 Feb; 60(3):560-5. PubMed ID: 10676637 [TBL] [Abstract][Full Text] [Related]
80. Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. Harnois DM; Que FG; Celli A; LaRusso NF; Gores GJ Hepatology; 1997 Oct; 26(4):884-90. PubMed ID: 9328309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]